Cornwall Live on MSN
Symptoms of glaucoma as cases to soar 60 per cent
Left untreated, glaucoma can lead to blindness ...
Cases of this eye condition are expected to increase to 1.6 million in the UK by 2060.
Swiss biotech Oculis is poised to start registration trials for privosegtor, its drug candidate for neuro-ophthalmic diseases, in the wake of encouraging phase 2 data. The Zug-based company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback